Author:
Viale G.,Basik M.,Niikura N.,Tokunaga E.,Brucker S.,Penault-Llorca F.,Hayashi N.,Sohn J.,Teixeira de Sousa R.,Brufsky A.M.,O’Brien C.S.,Schmitt F.,Higgins G.,Varghese D.,James G.D.,Moh A.,Livingston A.,de Giorgio-Miller V.
Reference36 articles.
1. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update;Wolff;J Clin Oncol,2018
2. Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer. V.4.2023. © National Comprehensive Cancer Network, Inc.; 2023. All rights reserved. Available at https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419. Accessed August 01, 2023. [To view the most recent and complete version of the guideline, go online to NCCN.org].
3. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer;Gennari;Ann Oncol,2021
4. Breast cancer;Loibl;Lancet,2021
5. Treatment of HER2-positive breast cancer: current status and future perspectives;Arteaga;Nat Rev Clin Oncol,2011
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献